Uptravi patent expiration date?

When Does Uptravi Patent Expiration Date?

The primary patent for Uptravi (selexipag) is set to expire in the United States in 2034 [1]. However, patent expiration dates can be complex and may vary by country [2].

What Happens After the Patent Expires?

Once patents expire, generic versions of a drug can potentially enter the market [3]. This often leads to increased competition and a decrease in drug prices [3].

Are There Other Patents or Exclusivities for Uptravi?

Drug patent landscapes can involve multiple patents, including method-of-use patents and formulation patents, which can extend market exclusivity beyond the expiration of the primary patent [2]. It is also possible for regulatory exclusivities, such as Orphan Drug Exclusivity or New Chemical Entity exclusivity, to be granted, providing additional periods of market protection [3]. For detailed information on specific patents and their expiration dates for Uptravi, DrugPatentWatch.com offers a comprehensive database [1].

Who Manufactures Uptravi?

Uptravi is manufactured by Actelion Pharmaceuticals Ltd. [1].